{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:11:42Z","timestamp":1768453902030,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jphs.2022.11.004","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T03:03:53Z","timestamp":1669691033000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Combinatorial screening for therapeutics in ATTRv amyloidosis identifies naphthoquinone analogues as TTR-selective amyloid disruptors"],"prefix":"10.1016","volume":"151","author":[{"given":"Ryoko","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ann","family":"Suico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Chosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Teranishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Hitora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineyuki","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1275-4988","authenticated-orcid":false,"given":"Tsuyoshi","family":"Shuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jphs.2022.11.004_bib1","article-title":"Senile systemic amyloidosis: clinical features at presentation and outcome","volume":"2","author":"Pinney","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jphs.2022.11.004_bib2","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation (amyloidogenesis in\u00a0vitro\/synthetic peptides\/electron microscopy\/secondary structure\/diabetes mellitus)","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.jphs.2022.11.004_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrd769","article-title":"Therapeutic strategies for human amyloid diseases","volume":"1","author":"Sacchettini","year":"2002","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.jphs.2022.11.004_bib4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/phar.2639","article-title":"Advances in the treatment of transthyretin cardiac amyloidosis: current and emerging therapies","volume":"41","author":"Warner","year":"2021","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.jphs.2022.11.004_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/WNL.0b013e318248df18","article-title":"Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy","volume":"78","author":"Yamashita","year":"2012","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.jphs.2022.11.004_bib6","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1111\/j.1600-6143.2007.01969.x","article-title":"Liver transplantation for familial amyloidotic polyneuropathy (fap): a single-center experience over 16 years","volume":"7","author":"Yamamoto","year":"2007","journal-title":"Am J Transplant"},{"issue":"18","key":"10.1016\/j.jphs.2022.11.004_bib7","doi-asserted-by":"crossref","first-page":"11887","DOI":"10.1074\/jbc.M709638200","article-title":"The modulation of transthyretin tetramer stability by cysteine 10 adducts and the drug diflunisal","volume":"283","author":"Kingsbury","year":"2008","journal-title":"J\u00a0Biol Chem"},{"issue":"24","key":"10.1016\/j.jphs.2022.11.004_bib8","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","author":"Bulawa","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jphs.2022.11.004_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","article-title":"Strategies, design, and chemistry in siRNA delivery systems","volume":"144","author":"Dong","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.jphs.2022.11.004_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"7618","key":"10.1016\/j.jphs.2022.11.004_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jphs.2022.11.004_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13195-021-00838-z","article-title":"Aducanumab produced a clinically meaningful benefit in association with amyloid lowering","volume":"13","author":"Cummings","year":"2021","journal-title":"Alzheimer's Res Ther"},{"issue":"4","key":"10.1016\/j.jphs.2022.11.004_bib13","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12213","article-title":"Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019","volume":"17","author":"Knopman","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"29","key":"10.1016\/j.jphs.2022.11.004_bib14","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1021\/bi1004409","article-title":"The crystal structure of the green tea polyphenol (-)-Epigallocatechin gallate?transthyretin complex reveals a novel binding site distinct from the thyroxine binding site","volume":"49","author":"Miyata","year":"2010","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.jphs.2022.11.004_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1021\/bi901677z","article-title":"Role of the glutamic acid 54 residue in transthyretin stability and thyroxine binding","volume":"49","author":"Miyata","year":"2010","journal-title":"Biochemistry"},{"issue":"20","key":"10.1016\/j.jphs.2022.11.004_bib16","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1021\/bi952501g","article-title":"The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid","volume":"35","author":"Lai","year":"1996","journal-title":"Biochemistry"},{"issue":"38","key":"10.1016\/j.jphs.2022.11.004_bib17","doi-asserted-by":"crossref","first-page":"11442","DOI":"10.1021\/bi011194d","article-title":"An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured","volume":"40","author":"Jiang","year":"2001","journal-title":"Biochemistry"},{"issue":"46","key":"10.1016\/j.jphs.2022.11.004_bib18","doi-asserted-by":"crossref","first-page":"32943","DOI":"10.1074\/jbc.274.46.32943","article-title":"The tetrameric protein transthyretin dissociates to a non-native monomer in solution","volume":"274","author":"Quintas","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jphs.2022.11.004_bib19","series-title":"HTS Assay Validation. Assay Guidance Manual","first-page":"1","author":"Iversen","year":"2012"},{"issue":"36","key":"10.1016\/j.jphs.2022.11.004_bib20","doi-asserted-by":"crossref","first-page":"14446","DOI":"10.1073\/pnas.1208228109","article-title":"Distinguishing crystal-like amyloid fibrils and glass-like amorphous aggregates from their kinetics of formation","volume":"109","author":"Yoshimura","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.jphs.2022.11.004_bib21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1107\/S0907444996003046","article-title":"Structures of human transthyretin complexed with thyroxine at 2.0 \u00c5 resolution and 3\u2019,5\u2019-dinitro-N-acetyl-l-thyronine at 2.2 \u00c5 resolution","volume":"52","author":"Wojtczak","year":"1996","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"26","key":"10.1016\/j.jphs.2022.11.004_bib22","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1021\/bi050249z","article-title":"The effect of iodide and chloride on transthyretin structure and stability","volume":"44","author":"H\u00f6rnberg","year":"2005","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.jphs.2022.11.004_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-08609-z","article-title":"A\u00a0molecular mechanism for transthyretin amyloidogenesis","volume":"10","author":"Yee","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jphs.2022.11.004_bib24","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1038\/s41467-019-13038-z","article-title":"Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis","volume":"10","author":"Schmidt","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jphs.2022.11.004_bib25","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1038\/s41467-019-12683-8","article-title":"Cryo-EM structure and polymorphism of A\u03b2 amyloid fibrils purified from Alzheimer's brain tissue","volume":"10","author":"Kollmer","year":"2019","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.jphs.2022.11.004_bib26","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/molecules24030500","article-title":"Transthyretin amyloid fibril disrupting activities of extracts and fractions from Juglans mandshurica maxim. Var. cordiformis (makino) kitam","volume":"24","author":"Chaudhary","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jphs.2022.11.004_bib27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.canlet.2019.04.033","article-title":"Shikonin derivatives for cancer prevention and therapy","volume":"459","author":"Boulos","year":"2019","journal-title":"Cancer Lett"},{"issue":"9","key":"10.1016\/j.jphs.2022.11.004_bib28","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/AAC.47.9.2810-2816.2003","article-title":"Shikonin, a component of Chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1","volume":"47","author":"Chen","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"13","key":"10.1016\/j.jphs.2022.11.004_bib29","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1016\/j.bmc.2006.02.026","article-title":"Antimalarial potential of xestoquinone, a protein kinase inhibitor isolated from a Vanuatu marine sponge Xestospongia sp","volume":"14","author":"Laurent","year":"2006","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"10.1016\/j.jphs.2022.11.004_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(00)00944-4","article-title":"Halenaquinone, a novel phosphatidylinositol 3-kinase inhibitor from a marine sponge, induces apoptosis in PC12 cells","volume":"413","author":"Fujiwara","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jphs.2022.11.004_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41598-017-18443-2","article-title":"Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids","volume":"8","author":"KrishnaKumar","year":"2018","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.jphs.2022.11.004_bib32","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1021\/acschemneuro.9b00123","article-title":"Antagonistic activity of naphthoquinone-based hybrids toward amyloids associated with Alzheimer's disease and type-2 diabetes","volume":"10","author":"Paul","year":"2019","journal-title":"ACS Chem Neurosci"},{"issue":"9","key":"10.1016\/j.jphs.2022.11.004_bib33","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1021\/acs.biomac.1c00344","article-title":"Evidence of anti-amyloid characteristics of plumbagin via inhibition of protein aggregation and disassembly of protein fibrils","volume":"22","author":"Anand","year":"2021","journal-title":"Biomacromolecules"},{"issue":"3","key":"10.1016\/j.jphs.2022.11.004_bib34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF02221030","article-title":"The deleterious effects of fungicides and herbicides on Xenopus laevis embryos","volume":"4","author":"Anderson","year":"1976","journal-title":"Arch Environ Contam Toxicol"},{"issue":"SUPPL. 1","key":"10.1016\/j.jphs.2022.11.004_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/13506129.2012.674988","article-title":"Potential use of glucuronylglucosyl-\u03b2-cyclodextrin as a novel therapeutic tool for familial amyloidotic polyneuropathy","volume":"19","author":"Jono","year":"2012","journal-title":"Amyloid"},{"issue":"25\u221226","key":"10.1016\/j.jphs.2022.11.004_bib36","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.lfs.2013.10.031","article-title":"Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy","volume":"93","author":"Taguchi","year":"2013","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.jphs.2022.11.004_bib37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbrc.2006.11.045","article-title":"A\u00a0transgenic rat with the human ATTR V30M: a novel tool for analyses of ATTR metabolisms","volume":"352","author":"Ueda","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"10.1016\/j.jphs.2022.11.004_bib38","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1039\/D0SC07089K","article-title":"Asymmetric total synthesis of (+)-xestoquinone and (+)-adociaquinones A and B","volume":"12","author":"Lu","year":"2021","journal-title":"Chem Sci"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861322000871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861322000871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:02:31Z","timestamp":1761163351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861322000871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1347861322000871"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2022.11.004","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combinatorial screening for therapeutics in ATTRv amyloidosis identifies naphthoquinone analogues as TTR-selective amyloid disruptors","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2022.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}